These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 20935166)
21. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770 [TBL] [Abstract][Full Text] [Related]
22. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269 [TBL] [Abstract][Full Text] [Related]
23. Identification of soluble forms of vascular endothelial growth factor receptors, sVEGFR-1 and sVEGFR-2, in bovine dominant follicles. Macias VR; Pinzón C; Fierro F; Vergara M; Martínez D; Rosado A; Gutiérrez CG; Rosales-Torres AM Reprod Domest Anim; 2012 Jun; 47(3):e39-42. PubMed ID: 21988522 [TBL] [Abstract][Full Text] [Related]
24. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor. Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256 [TBL] [Abstract][Full Text] [Related]
25. Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model. Ji K; Minakawa M; Fukui K; Suzuki Y; Fukuda I Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):210-7. PubMed ID: 18818569 [TBL] [Abstract][Full Text] [Related]
26. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Wada H; Satoh N; Kitaoka S; Ono K; Morimoto T; Kawamura T; Nakano T; Fujita M; Kita T; Shimatsu A; Hasegawa K Atherosclerosis; 2010 Feb; 208(2):512-7. PubMed ID: 19695569 [TBL] [Abstract][Full Text] [Related]
27. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Hornig C; Barleon B; Ahmad S; Vuorela P; Ahmed A; Weich HA Lab Invest; 2000 Apr; 80(4):443-54. PubMed ID: 10780661 [TBL] [Abstract][Full Text] [Related]
28. Expression of VEGF and its receptors in different brain tumors. Huang H; Held-Feindt J; Buhl R; Mehdorn HM; Mentlein R Neurol Res; 2005 Jun; 27(4):371-7. PubMed ID: 15949234 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor and its soluble receptors-1 and -2 in iris neovascularization and neovascular glaucoma. Noma H; Mimura T; Yasuda K; Shimura M Ophthalmologica; 2014; 232(2):102-9. PubMed ID: 24942011 [TBL] [Abstract][Full Text] [Related]
30. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes. Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179 [TBL] [Abstract][Full Text] [Related]
31. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2. Zhao B; Cai J; Boulton M Microvasc Res; 2004 Nov; 68(3):239-46. PubMed ID: 15501243 [TBL] [Abstract][Full Text] [Related]
32. Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. Garvin S; Nilsson UW; Dabrosin C Br J Cancer; 2005 Oct; 93(9):1005-10. PubMed ID: 16234819 [TBL] [Abstract][Full Text] [Related]